The Estée Lauder Companies announced on January 10, 2025, that Ronald S. Lauder retired from the company's Board of Directors, effective immediately. Mr. Lauder had served on the Board for over 50 years in various capacities.
Pursuant to a stockholders' agreement, Mr. Lauder designated his son-in-law, Eric Zinterhofer, to join the Board, and Mr. Zinterhofer was elected effective immediately. Ronald Lauder will continue to serve as Chairman of Clinique Laboratories, LLC.
Eric Zinterhofer brings extensive financial, investing, and global business experience to the Board, currently serving as a Founding Partner of Searchlight Capital Partners. This transition reflects an evolution in the Lauder family's representation on the Board.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.